HomeAI · summaries
Storia in 16 fonti
Cancer breakthrough as new 'game-changing' pill could double survival time
Prostate cancer patients normally have a devastatingly short life expectancy - but the new daily pill being offered in clinical trials could change that
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
pbs.org
Pancreatic cancer is deadly and difficult to treat. A new pill could change that
The overall survival rate for people who got daraxonrasib was 13.2 months, nearly double the 6.7 months people survived on standard chemotherapy alone.
- ·
independent.co.uk
Daily pill almost doubles survival time for pancreatic cancer patients in new trial
Daraxonrasib has been hailed as ‘landscape-changing’ for people with the disease
- ·
dailymail.com
Hope for thousands as new drug cuts prostate cancer relapse risk
Thousands of men with advanced prostate cancer could soon live longer thanks to a treatment which cuts the risk of the disease returning by nearly a third.
- ·
theguardian.com
Daily pill can double survival time for world’s deadliest cancer, trial shows
Experts hail daraxonrasib as ‘gamechanger’ for patients with advanced pancreatic cancer
- ·
New drug gives extra months of life to pancreatic cancer patients
Doctors today hailed a breakthrough in the fight against pancreatic cancer after a new drug was shown to give patients precious extra months of life.
- ·
Experimental pill promises new hope for deadly pancreatic cancer
New research shows a novel pill is helping people with advanced pancreatic cancer live longer
- ·
mirror.co.uk
Cancer breakthrough as new 'game-changing' pill could double survival time
Prostate cancer patients normally have a devastatingly short life expectancy - but the new daily pill being offered in clinical trials could change that
- ·
Pancreatic cancer breakthrough as pill almost doubles survival time for patients
Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank you for registeringPlease refresh the page or…
- ·
cbsnews.com
New drug nearly doubles survival rates in some pancreatic cancer patients, study says
New research shows a medication called daraxonrasib is helping people with advanced pancreatic cancer live longer.
- ·
fortune.com
Experimental pill nearly doubles survival time for people with advanced pancreatic cancer. 'I actually started crying' | Fortune
The drug is called daraxonrasib and it blocks a mutated protein that fuels tumor growth in more than 90% of pancreatic cancer cases — a target that had eluded treatment for…
- ·
cnn.com
Experimental pill promises new hope for deadly pancreatic cancer | CNN
A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types…
- ·
dailysabah.com
Experimental pill offers breakthrough hope in pancreatic cancer fight
An experimental drug for advanced pancreatic cancer significantly extended survival in a major clinical trial, offering fresh hope for improved treatment...
- ·
inews.co.uk
Why this new pill for a deadly cancer has doctors excited
The results of a clinical trial of a new drug could signal a breakthrough in treating pancreatic cancer
- ·
quotidianodelsud.it
Cancro al pancreas, un nuovo farmaco raddoppia il periodo di sopravvivenza: lo studio - Il Quotidiano del Sud
2 minuti per la lettura (Adnkronos) – Una pillola, presa ogni giorno, può raddoppiare il periodo di sopravvivenza per i pazienti colpiti da cancro al pancreas. Sono i risultati di…
- ·
Experimental drug shows promise against deadly pancreatic cancer
A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types…
- ·
sciencealert.com
Breakthrough Pill Nearly Doubles Survival Time For One of The Deadliest Cancers
WASHINGTON (AP) – A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of…
- ·
newsbytesapp.com
This drug can double survival time for pancreatic cancer patients
A groundbreaking daily pill has been shown to double survival time for patients battling the world's deadliest cancer, marking a major advancement in medical research.
- ·
abcnews.com
Experimental pancreatic cancer drug offers new hope in major trial
Phase 3 results showed the treatment nearly doubled survival for patients with previously treated metastatic pancreatic cancer.
- ·
theweek.com
Pill offers hope in treating deadly pancreatic cancer
Pill users lived an average of 13.2 months versus 6.7 months for those undergoing chemotherapy
- ·
newscientist.com
'Transformative' pancreatic cancer drug doubles survival time
People with advanced pancreatic cancer taking an experimental daily pill lived nearly twice as long as those receiving chemotherapy infusions